MEPs accuse the European Commission of caving in to US pharmaceutical interests after a trade deal with Trump.
Emese Grancsa
International
Credit: Jacquelyn Martin / AP / Profimedia
Always see our news on Google
Ursula von der Leyen has been criticized by cross-party MEPs over the trade deal with Donald Trump, which excludes pharmaceuticals from tariffs but allows a 15% cap. Many voices in the European People's Party (EPP) and other political groups believe the deal favors the US and weakens the European Union's position. Additional critics are calling for transparency and publication of the details of the deal, pointing out that while economically it is an improvement, it is a political defeat for the EU.
Sources
Eurodeputaţii o acuză pe Ursula von der Leyen că și-a depășit mandatul și a cedat în faţa intereselor americane
Eurodeputații critică acordul negociat de către Ursula von der Leyen cu Donald Trump: „Ambele părţi trebuie să câştige ceva”
'O zi sumbră pentru Europa'. Franța critică acordul comercial dintre UE și SUA
UE: „Nu am luat încă nicio decizie cu privire la web tax”
Latest News
09:16
Devastating fire at a social housing complex in Săcălaz, Timiș
09:02
The United States has imposed tariffs of 50% on Canadian products worth 20 billion dollars, and Canada has announced that it will retaliate.
08:41
Romania is taking emergency measures to ensure the necessary water supply for the Cernavodă Power Plant, in the context of the decreasing flow of the Danube.
08:28
Prince Harry, Elton John and other celebrities have been ordered by the court to pay millions of pounds in the lawsuit against "The Daily Mail".
08:19
American planes are flying over the Taiwan Strait, confirming the commitment of the USA
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
